LISSA RHODES: Open Payments
NPI 1467987099 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 32 payments from 15 companies in 2025. Trend: 2023 $551 · 2024 $597 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $75 |
| ABBVIE INC. | 4 | $69 |
| MERZ NORTH AMERICA, INC. | 2 | $54 |
| Janssen Biotech, Inc. | 3 | $51 |
| UCB, Inc. | 2 | $51 |
| Organon LLC | 3 | $47 |
| Lilly USA, LLC | 2 | $43 |
| GENZYME CORPORATION | 2 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Amgen Inc. | 2 | $33 |
Products named: SKYRIZI, Xeomin, TREMFYA, Bimzelx, AKLIEF, DUPIXENT, OTEZLA, NEMLUVIO.
Industry payments across TN — which companies pay providers there.
